---
title: "North Immunology: Hedge-fund–backed startup developing long-acting antibody for atopic dermatitis"
id: "stat-news-0-stat-a-biotech-hedge-fund-births-a-new-immunology-company"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-0-stat-a-biotech-hedge-fund-births-a-new-immunology-company"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/09/17/biotech-hedge-fund-startup-north-immunology/?utm_campaign=rss"
published_at: "2026-09-17T10:30:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# North Immunology: Hedge-fund–backed startup developing long-acting antibody for atopic dermatitis
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-0-stat-a-biotech-hedge-fund-births-a-new-immunology-company
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/09/17/biotech-hedge-fund-startup-north-immunology/?utm_campaign=rss)
- **Published At:** 2026-09-17T10:30:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The STAT News piece reports that a new company, **North Immunology**, has been formed to pursue a long-acting antibody treatment for **atopic dermatitis**. - The idea originated when analyst Mohit Gupta, who works for Dan Schneeberger at Adar1 Capital, pitched the concept to Schneeberger in his Austin office two years ago. - Dan Schneeberger’s primary role at Adar1 Capital is as an investor in existing biotech companies; founding a company is not his usual activity. - The article notes that North Immunology is focused on developing a better, long-acting antibody therapy for atopic dermatitis but provides no further clinical or program details in the publicly available excerpt. - The story is a STAT+ subscriber piece; the full article is behind a paywall and requires subscription or login to read remaining content. - The published item includes standard STAT News metadata: author (Adam Feuerstein), publication date (Sept. 17, 2026), and placement in biotech/drug-development coverage. - The publicly visible portion includes a captioned image indicating North Immunology is developing a long-acting antibody for atopic dermatitis. - Specifics such as funding size, scientific approach, preclinical or clinical data, leadership team beyond Gupta and Schneeberger, timelines, partnerships, intellectual property, and regulatory strategy were not reported in the accessible portion of the source.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/09/17/biotech-hedge-fund-startup-north-immunology/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/09/17/biotech-hedge-fund-startup-north-immunology/?utm_campaign=rss) [research](https://www.statnews.com/topic/research/) [NIH](https://www.statnews.com/topic/nih/) [Trump](https://www.statnews.com/topic/trump/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT Events](https://www.statnews.com/events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) My Account * [Settings](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing History](https://www.statnews.com/my-account/billing/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds-nominate/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [STAT Plus](https://www.statnews.com/stat-plus/)Opinion[Adam’s Biotech Scorecard](https://www.statnews.com/category/adams-biotech-scorecard/) # A biotech hedge fund births a new immunology company ## North Immunology is seeking to develop a better treatment for atopic dermatitis * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/09/17/biotech-hedge-fund-startup-north-immunology/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2025/12/AdobeStock_1649079417-645x645.jpeg) North Immunology is developing a long-acting antibody treatment for atopic dermatitis.Adobe ![](https://www.statnews.com/wp-content/uploads/2021/02/adam-f-avatar-small2-80x80.png) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) Sept. 17, 2026 Senior Writer, Biotech ![](https://www.statnews.com/wp-content/uploads/2021/02/adam-f-avatar-small2-80x80.png) [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 1. [](https://x.com/adamfeuerstein "X") adam.feuerstein@statnews.com Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast [The Readout Loud](https://www.statnews.com/category/readout-loud/) and author of the newsletter [Adam’s Biotech Scorecard.](https://www.statnews.com/signup/scorecard/) You can reach Adam on Signal at stataf.54. [Get email alerts for Adam FeuersteinSigned up for email alertsRemove email alerts](https://www.statnews.com/2026/09/17/biotech-hedge-fund-startup-north-immunology/?utm_campaign=rss) [Subscribe](https://www.statnews.com/stat-plus/) or [log in](https://www.statnews.com/login/) to STAT+ to unlock email alerts _This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up[here](https://www.statnews.com/signup/scorecard/) to get it delivered to their inbox._ Two years ago, Mohit Gupta, an analyst who works for Adar1 Capital’s Dan Schneeberger, walked into Schneeberger’s Austin, Texas, office and pitched an idea to build from the ground up a new company to develop a better, long-acting antibody treatment for atopic dermatitis. Advertisement Schneeberger’s day job, of course, is to invest in biotech companies that are already developing drugs, not start one on his own. [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [biotechnology](https://www.statnews.com/topic/biotechnology/), [chronic diseases](https://www.statnews.com/topic/chronic-diseases/), [drug development](https://www.statnews.com/topic/drug-development/), [Pharmaceuticals](https://www.statnews.com/topic/pharmaceuticals/), [STAT+](https://www.statnews.com/topic/stat-plus/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2021/02/adam-f-avatar-small2-80x80.png) [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 1. [](https://x.com/adamfeuerstein "X") 2. Senior Writer, Biotech 1. [](https://x.com/adamfeuerstein "X") 2. Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast [The Readout Loud](https://www.statnews.com/category/readout-loud/) and author of the newsletter [Adam’s Biotech Scorecard.](https://www.statnews.com/signup/scorecard/) You can reach Adam on Signal at stataf.54. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2024/03/Biotech-Scorecard-Logo-NoSTAT-640x290.png) ### STAT+ Newsletter Senior writer Adam Feuerstein's unfiltered, uncompromising analysis on the biotech world Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/09/Image-3-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Scientists made mice with half a brain. Then they filled them with human organoids](https://www.statnews.com/2026/09/16/human-brain-organoids-neuro-chimeric-mice-study-published-nature/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/09/fda-hiring-edit-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [The FDA’s rebuilding effort is running into a new challenge](https://www.statnews.com/2026/09/17/fda-doge-cuts-new-hires-slowed-centralized-hiring-center-short-staffed/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/09/AdobeStock_419260729_Editorial_Use_Only-80x80.jpeg) [New lawsuit argues NIH violated First Amendment rights of grant applicants](https://www.statnews.com/2026/09/16/lawsuit-argues-nih-violated-researcher-first-amendment-rights-aclu/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/06/GettyImages-2237096018-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing deal](https://www.statnews.com/2026/09/17/astrazeneca-enhertu-breast-cancer-england-nice-pricing-agreement-us-trade-deal/) 5. ![](https://www.statnews.com/wp-content/uploads/2025/12/AdobeStock_288008063-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Vera kidney drug Trutakna shows strong final results in Phase 3 trial](https://www.statnews.com/2026/09/15/vera-kidney-drug-trutakna-shows-strong-phase-3-results-igan/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/924_Samsung_VirtualEvent_Wordpress_FeaturedImage-80x80.jpg) Biosimilars: Have We Reached an Inflection Point? Virtual Sep 24 ](https://www.statnews.com/event/biosimilars-what-is-next-virtual-event-sept-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/01/Flagship2026_Wordpress_CalendarImageRegGoLive-1-80x80.jpg) 2026 STAT Summit Boston, MA Oct 14 ](https://www.statnews.com/event/2026-stat-summit/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_DD_OfficeHours_VirtualEvent_Wordpress_CalendarImage-80x80.jpg) Office Hours with Isabella Cueto and Lev Facher Virtual Jul 29 ](https://www.statnews.com/event/deadliest-drug-series-office-hours-ama-july-2026/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2025/12/AdobeStock_288008063-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Vera kidney drug Trutakna shows strong final results in Phase 3 trial](https://www.statnews.com/2026/09/15/vera-kidney-drug-trutakna-shows-strong-phase-3-results-igan/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/09/Screenshot-2026-09-10-at-11.16.19-AM-e1789064257681-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field](https://www.statnews.com/2026/09/11/novartis-novo-nordisk-cardiovascular-drug-trials-fallout/) 3. ![](https://www.statnews.com/wp-content/uploads/2016/09/Infusion_AP_328963423903-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Scholar Rock wins FDA approval for first drug to target SMA muscle loss](https://www.statnews.com/2026/09/11/scholar-rock-spinal-muscular-atrophy-isembyld-clinical-trial-fda-approval/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/09/GettyImages-2292889136-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Medicare to expand its pilot that pays for technology to manage chronic diseases](https://www.statnews.com/2026/09/15/medicare-access-chronic-care-management-tech-pilot-expanding/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/09/AdobeStock_1144154192-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Medicare’s AI prior authorization pilot was rushed and full of problems, new documents reveal](https://www.statnews.com/2026/09/15/medicare-wiser-ai-prior-authorization-pilot-rushed-launch-delayed-care/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Adam's Biotech Scorecard Adam's Biotech Scorecard September 17, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: A Sellas immunotherapy study, long delayed, will end in failure ](https://www.statnews.com/2026/09/17/sellas-immunotherapy-study-acute-myeloid-leukemia/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Adam's Biotech Scorecard Adam's Biotech Scorecard September 10, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Roivant is one of the savviest dealmakers in biotech. It also has a secret weapon ](https://www.statnews.com/2026/09/10/roivant-biotech-dealmaking-mosliciguat-origins/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Adam's Biotech Scorecard Adam's Biotech Scorecard September 10, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: What to expect from UniQure’s upcoming Huntington’s gene therapy readout ](https://www.statnews.com/2026/09/10/uniqure-huntingtons-gene-therapy-trial-readout/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Adam's Biotech Scorecard Adam's Biotech Scorecard September 3, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Abivax has still not been acquired. What’s going on? ](https://www.statnews.com/2026/09/03/abivax-acquisition-target-replimune-fda/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Adam's Biotech Scorecard Adam's Biotech Scorecard August 27, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Alnylam’s heart drug troubles take center stage at a cardiology conference ](https://www.statnews.com/2026/08/27/alnylam-amvuttra-nucresiran-heart-drugs-esc/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field ](https://www.statnews.com/2026/09/11/novartis-novo-nordisk-cardiovascular-drug-trials-fallout/) By [Allison DeAngelis](https://www.statnews.com/staff/allison-deangelis/) and [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 2. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: What to expect from UniQure's upcoming Huntington's gene therapy readout ](https://www.statnews.com/2026/09/10/uniqure-huntingtons-gene-therapy-trial-readout/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 3. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Medicare's AI prior authorization pilot was rushed and full of problems, new documents reveal ](https://www.statnews.com/2026/09/15/medicare-wiser-ai-prior-authorization-pilot-rushed-launch-delayed-care/) By [Brittany Trang](https://www.statnews.com/staff/brittany-trang/) 4. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Roivant is one of the savviest dealmakers in biotech. It also has a secret weapon ](https://www.statnews.com/2026/09/10/roivant-biotech-dealmaking-mosliciguat-origins/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 5. ### [ Trump officials say AI will help save rural health care. Some leaders in the field don’t believe it ](https://www.statnews.com/2026/09/10/rural-health-care-ai-adoption-challenges-part-4-unraveled-series/) By [Daniel Payne](https://www.statnews.com/staff/daniel-payne/) Share options * [ X ](https://twitter.com/intent/tweet?url=https://www.statnews.com/2026/09/17/biotech-hedge-fund-startup-north-immunology/&via=statnews&te
## Related Clinical Research

- [Why AI for Older Adults Requires Careful Scrutiny, a Geriatrician Warns](https://medichelpline.com/clinical-feed/stat-news-3-stat-a-geriatrician-explains-why-ai-for-older-adults-deserves-careful-scrutiny.md)
- [House Democrats Prepare Oversight Strategy Targeting Health Care and Drug Pricing](https://medichelpline.com/clinical-feed/stat-news-0-stat-house-democrats-may-use-oversight-powers-to-plan-for-health-care-overhaul.md)
- [Keto Diet Shows Superior Metabolic Benefits Over Mediterranean and Low-Fat Diets](https://medichelpline.com/clinical-feed/medical-news-today-1-keto-diet-may-have-metabolic-advantages-over-mediterranean-low-fat-diets.md)
- [Coffee consumption associated with lower visceral fat, higher muscle mass, and hormonal differences](https://medichelpline.com/clinical-feed/medical-news-today-0-coffee-drinking-linked-to-less-abdominal-fat-more-muscle-better-hormone-balance.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.